Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Siren Siren +24.63%
#3 Ankr Network Ankr Network +20.58%
#4 Pons Pons +15.45%
#5 BankrCoin BankrCoin +12.99%
#6 Status Status +12.49%
#7 ICON ICON +11.08%
#8 Wiki Cat Wiki Cat +9.82%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.16%
#10 RedStone RedStone +6.88%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Rank in Stocks #18094
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Share Price
$10.22
Last synced: 2026-07-31
Market Cap
$212.97M
Change (1 day)
4.58%
Change (1 year)
78.08%
Country
CA
Trade Satellos Bioscience Inc. (MSCL)

Category

Healthcare
Revenue for Satellos Bioscience Inc. (MSCL)
Revenue in Sep 2026 TTM: 0
According to Satellos Bioscience Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Satellos Bioscience Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH